Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Workers' Comp
News Release
Mitchell | Genex Sign Agreement to Acquire Coventry 3-2-20
Workers' Comp
Virtual Event
Webinar: Aging Workforce, Medication Safety and Cyber Security
On-Demand
Over the past 10 years, workers' compensation claim frequency has been steadily decreasing, but at the same time, severity has been on the rise and
Workers' Comp
News Release
Business Insurance: Insurers could face stiff Medicare secondary payer penalties
A long-awaited proposed rule regarding late reporting of Medicare Secondary Payer data could mean potentially significant penalties for worke
Workers' Comp
Article
Return to Work Program Benefits & Strategies
Developing successful return to work (RTW) plans is instrumental to efficient and effective workers’ compensation claims management.
Mitchell
News Release
Mitchell Announces Third Party Medicare Module Available in DecisionPoint Platform
Workers' Comp
Article
CMS Announces Proposed Methods to Calculate Civil Monetary Penalties for Section 111 Reporting
Keep current with new legislation and its potential effect on your organization.